Therapeutic effect of the drug of Parkinson`s disease on voiding dysfunctio
Phase 1
- Conditions
- patients with voiding dysfunction such as benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000013063
- Lead Sponsor
- Shinshu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
# neurogenic bladder, bladder neck contracture, urethral stricture, urinary tract infection or other complication # clear intermittent self catheterization # allergic to the drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method voiding efficacy (Qmax)
- Secondary Outcome Measures
Name Time Method urinary frequency questionaires for urinary symptom